2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Abstract Atrial fibrillation (AF) is an extremely common clinical problem with an important population morbidity and mortality burden. The management of AF is complex and fraught with many uncertain and contentious issues, which are being addressed by extensive ongoing basic and clinical research. T...
Saved in:
| Published in | Canadian journal of cardiology Vol. 30; no. 10; pp. 1114 - 1130 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Inc
01.10.2014
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Abstract Atrial fibrillation (AF) is an extremely common clinical problem with an important population morbidity and mortality burden. The management of AF is complex and fraught with many uncertain and contentious issues, which are being addressed by extensive ongoing basic and clinical research. The Canadian Cardiovascular Society AF Guidelines Committee produced an extensive set of evidence-based AF management guidelines in 2010 and updated them in the areas of anticoagulation and rate/rhythm control in 2012. In late 2013, the committee judged that sufficient new information regarding AF management had become available since 2012 to warrant an update to the Canadian Cardiovascular Society AF Guidelines. After extensive evaluation of the new evidence, the committee has updated the guidelines for: (1) stroke prevention principles; (2) anticoagulation of AF patients with chronic kidney disease; (3) detection of AF in patients with stroke; (4) investigation and management of subclinical AF; (5) left atrial appendage closure in stroke prevention; (6) emergency department management of AF; (7) periprocedural anticoagulation management; and (8) rate and rhythm control including catheter ablation. This report presents the details of the updated recommendations, along with their background and rationale. In addition, a complete set of presently applicable recommendations, those that have been updated and those that remain in force from previous guideline versions, is provided in the Supplementary Material. |
|---|---|
| AbstractList | Abstract Atrial fibrillation (AF) is an extremely common clinical problem with an important population morbidity and mortality burden. The management of AF is complex and fraught with many uncertain and contentious issues, which are being addressed by extensive ongoing basic and clinical research. The Canadian Cardiovascular Society AF Guidelines Committee produced an extensive set of evidence-based AF management guidelines in 2010 and updated them in the areas of anticoagulation and rate/rhythm control in 2012. In late 2013, the committee judged that sufficient new information regarding AF management had become available since 2012 to warrant an update to the Canadian Cardiovascular Society AF Guidelines. After extensive evaluation of the new evidence, the committee has updated the guidelines for: (1) stroke prevention principles; (2) anticoagulation of AF patients with chronic kidney disease; (3) detection of AF in patients with stroke; (4) investigation and management of subclinical AF; (5) left atrial appendage closure in stroke prevention; (6) emergency department management of AF; (7) periprocedural anticoagulation management; and (8) rate and rhythm control including catheter ablation. This report presents the details of the updated recommendations, along with their background and rationale. In addition, a complete set of presently applicable recommendations, those that have been updated and those that remain in force from previous guideline versions, is provided in the Supplementary Material. Atrial fibrillation (AF) is an extremely common clinical problem with an important population morbidity and mortality burden. The management of AF is complex and fraught with many uncertain and contentious issues, which are being addressed by extensive ongoing basic and clinical research. The Canadian Cardiovascular Society AF Guidelines Committee produced an extensive set of evidence-based AF management guidelines in 2010 and updated them in the areas of anticoagulation and rate/rhythm control in 2012. In late 2013, the committee judged that sufficient new information regarding AF management had become available since 2012 to warrant an update to the Canadian Cardiovascular Society AF Guidelines. After extensive evaluation of the new evidence, the committee has updated the guidelines for: (1) stroke prevention principles; (2) anticoagulation of AF patients with chronic kidney disease; (3) detection of AF in patients with stroke; (4) investigation and management of subclinical AF; (5) left atrial appendage closure in stroke prevention; (6) emergency department management of AF; (7) periprocedural anticoagulation management; and (8) rate and rhythm control including catheter ablation. This report presents the details of the updated recommendations, along with their background and rationale. In addition, a complete set of presently applicable recommendations, those that have been updated and those that remain in force from previous guideline versions, is provided in the Supplementary Material. Atrial fibrillation (AF) is an extremely common clinical problem with an important population morbidity and mortality burden. The management of AF is complex and fraught with many uncertain and contentious issues, which are being addressed by extensive ongoing basic and clinical research. The Canadian Cardiovascular Society AF Guidelines Committee produced an extensive set of evidence-based AF management guidelines in 2010 and updated them in the areas of anticoagulation and rate/rhythm control in 2012. In late 2013, the committee judged that sufficient new information regarding AF management had become available since 2012 to warrant an update to the Canadian Cardiovascular Society AF Guidelines. After extensive evaluation of the new evidence, the committee has updated the guidelines for: (1) stroke prevention principles; (2) anticoagulation of AF patients with chronic kidney disease; (3) detection of AF in patients with stroke; (4) investigation and management of subclinical AF; (5) left atrial appendage closure in stroke prevention; (6) emergency department management of AF; (7) periprocedural anticoagulation management; and (8) rate and rhythm control including catheter ablation. This report presents the details of the updated recommendations, along with their background and rationale. In addition, a complete set of presently applicable recommendations, those that have been updated and those that remain in force from previous guideline versions, is provided in the Supplementary Material. La fibrillation auriculaire (FA) est un problème clinique très fréquent représentant un fardeau important de la morbidité et de la mortalité de la population. La prise en charge de la FA est complexe et comporte plusieurs questions incertaines et controversées, qui sont actuellement abordées par la recherche fondamentale et clinique approfondie. En 2010, le comité des lignes directrices sur la FA de la Société canadienne de cardiologie a produit un vaste ensemble de lignes directrices sur la prise en charge de la FA fondées sur des données probantes et les a mises à jour en 2012 dans les domaines de l’anticoagulation du contrôle de la fréquence et du rythme. À la fin de 2013, le comité a estimé que les nouvelles informations sur la prise en charge de la FA qui sont disponibles depuis 2012 étaient suffisantes pour justifier une mise à jour des lignes directrices sur la FA de la Société canadienne de cardiologie. Après l’évaluation approfondie des nouvelles données probantes, le comité a mis à jour les lignes directrices sur : 1) les principes de prévention de l’accident vasculaire cérébral; 2) l’anticoagulation des patients atteints d’une maladie rénale chronique qui ont une FA; 3) la détection de la FA chez les patients qui subissent un accident vasculaire cérébral; 4) l’évaluation et la prise en charge de la FA subclinique; 5) la fermeture de l’appendice auriculaire gauche dans la prévention de l’accident vasculaire cérébral; 6) la prise en charge de la FA par le service des urgences; 7) la prise en charge péri-interventionnelle de l’anticoagulation; 8) le contrôle de la fréquence et du rythme, y compris l’ablation par cathéter. Ce rapport présente de manière détaillée les recommandations mises à jour, ainsi que leur fondement et leurs justifications. De plus, l’ensemble des recommandations actuellement applicables, celles qui ont été mises à jour et celles des versions précédentes des lignes directrices qui demeurent en vigueur, est fourni dans une Liste complète des lignes directrices comme documentation complémentaire. |
| Author | Stiell, Ian G., MD Mitchell, L. Brent, MD Ivers, Noah, MD Connolly, Stuart, MD Cox, Jafna L., MD Healey, Jeff S., MD Gladstone, David, MD Macle, Laurent, MD Verma, Atul, MD McMurtry, Michael Sean, MD Leblanc, Kori, PharmD Dorian, Paul, MD Cairns, John A., MD Nattel, Stanley, MD |
| Author_xml | – sequence: 1 fullname: Verma, Atul, MD – sequence: 2 fullname: Cairns, John A., MD – sequence: 3 fullname: Mitchell, L. Brent, MD – sequence: 4 fullname: Macle, Laurent, MD – sequence: 5 fullname: Stiell, Ian G., MD – sequence: 6 fullname: Gladstone, David, MD – sequence: 7 fullname: McMurtry, Michael Sean, MD – sequence: 8 fullname: Connolly, Stuart, MD – sequence: 9 fullname: Cox, Jafna L., MD – sequence: 10 fullname: Dorian, Paul, MD – sequence: 11 fullname: Ivers, Noah, MD – sequence: 12 fullname: Leblanc, Kori, PharmD – sequence: 13 fullname: Nattel, Stanley, MD – sequence: 14 fullname: Healey, Jeff S., MD |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25262857$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kcFu1DAQhi1URLctL8AB5cgl6dhJbEdCSNWKbSsVcWgrcbO89gQcsvZiJ5X27XHYwqEHTp7D__3yfHNGTnzwSMg7ChUFyi-HygxGVwxoU4GsAOgrsqId5aUA0Z6QFUgmSybZt1NyltIA0FAh-BtyylrGmWzFioSFLjbBzAlt8bi3esIi9MX0A4u19to67fMQrQtPOpl51LG4D8bhdCiuZ2dxdB5T0Yf4B_mSke-4Qz8tJVdTdHosNm4b3TjqyQV_QV73ekz49vk9J4-bzw_rm_Lu6_Xt-uquNI0QU0nbjutWSiO321Y3Umtmutoa0Hk_0-pOU84YNMCoqPuay64DJlAKCaJDa-tz8uHYu4_h14xpUjuXDOZfeAxzUrTlvAFZC56j7Bg1MaQUsVf76HY6HhQFtYhWg1pEq0WVAqmy6Ay9f-6ftzu0_5C_ZnPg4zGAecsnh1GlbM0btC6imZQN7v_9n17gJpt2Ro8_8YBpCHP02Z-iKjEF6n459XJp2gBlTdfWvwHjfqRx |
| CitedBy_id | crossref_primary_10_1136_heartjnl_2014_307030 crossref_primary_10_1016_j_cjca_2015_10_029 crossref_primary_10_1016_j_cjca_2015_02_027 crossref_primary_10_1080_17482941_2017_1406954 crossref_primary_10_1586_14779072_2015_1026259 crossref_primary_10_1016_j_jacc_2019_11_033 crossref_primary_10_1093_ndt_gfx322 crossref_primary_10_1097_HCO_0000000000000475 crossref_primary_10_1016_j_ahj_2024_04_016 crossref_primary_10_1016_j_ahj_2018_06_005 crossref_primary_10_1016_j_jacep_2016_09_003 crossref_primary_10_1161_JAHA_117_006022 crossref_primary_10_1136_bmj_k1717 crossref_primary_10_1139_apnm_2015_0356 crossref_primary_10_3904_kjm_2019_94_2_191 crossref_primary_10_1016_j_cjca_2015_09_023 crossref_primary_10_1002_clc_23316 crossref_primary_10_1016_j_cjca_2019_05_009 crossref_primary_10_1097_CRD_0000000000000312 crossref_primary_10_2459_JCM_0000000000000662 crossref_primary_10_5867_medwave_2016_01_6381 crossref_primary_10_1016_j_annemergmed_2015_07_012 crossref_primary_10_1111_1755_5922_12254 crossref_primary_10_1093_eurheartj_ehx795 crossref_primary_10_1111_joim_12702 crossref_primary_10_1097_HCO_0000000000000347 crossref_primary_10_1016_j_ijcard_2015_05_115 crossref_primary_10_1016_j_ijcard_2016_07_243 crossref_primary_10_1093_europace_euw116 crossref_primary_10_1093_europace_euab087 crossref_primary_10_1161_CIR_0000000000000311 crossref_primary_10_1016_j_ijcard_2016_11_015 crossref_primary_10_1161_STROKEAHA_117_018395 crossref_primary_10_1007_s40620_016_0374_6 crossref_primary_10_1016_j_cjca_2018_07_483 crossref_primary_10_1016_j_ipej_2016_11_012 crossref_primary_10_1093_eurheartj_ehu494 crossref_primary_10_1007_s43678_020_00067_7 crossref_primary_10_1017_S1463423617000196 crossref_primary_10_1136_bmjopen_2021_057991 crossref_primary_10_1253_circj_CJ_20_0594 crossref_primary_10_1177_21501319231164060 crossref_primary_10_1016_j_semnephrol_2023_151478 crossref_primary_10_1016_j_amjmed_2018_03_024 crossref_primary_10_1080_00325481_2015_1029863 crossref_primary_10_2217_fca_2016_0070 crossref_primary_10_1017_cjn_2023_55 crossref_primary_10_1177_2054358119892372 crossref_primary_10_1177_0272989X15593083 crossref_primary_10_1177_1747493016660106 crossref_primary_10_1016_j_mpaic_2015_02_009 crossref_primary_10_1177_1715163519853307 crossref_primary_10_1136_bmjebm_2018_111057 crossref_primary_10_3390_jcm11071823 crossref_primary_10_5867_medwave_2016_01_6365 crossref_primary_10_1016_j_rccar_2016_10_010 crossref_primary_10_1016_j_jjcc_2018_03_002 crossref_primary_10_1016_j_rccar_2016_10_013 crossref_primary_10_1016_j_cjca_2018_12_013 crossref_primary_10_1016_j_cjca_2018_07_476 crossref_primary_10_1016_j_cjca_2017_01_003 crossref_primary_10_1016_j_cjca_2018_08_026 crossref_primary_10_1161_STROKEAHA_115_012195 crossref_primary_10_15690_vramn1116 crossref_primary_10_1017_cem_2017_371 crossref_primary_10_1111_ijs_12439 crossref_primary_10_1007_s40256_016_0163_6 crossref_primary_10_1016_j_amjcard_2019_10_033 crossref_primary_10_1093_ehjcvp_pvab076 crossref_primary_10_1002_14651858_CD012385 crossref_primary_10_1016_j_ccl_2015_12_006 crossref_primary_10_1161_CIRCEP_118_006582 crossref_primary_10_1016_j_ajem_2016_05_013 crossref_primary_10_1016_j_cjca_2015_05_012 crossref_primary_10_1136_bmjopen_2017_017577 crossref_primary_10_1177_2054358117735532 crossref_primary_10_1177_1753495X16685684 crossref_primary_10_2147_MDER_S245625 crossref_primary_10_1016_j_cjca_2016_06_003 crossref_primary_10_1111_bcp_14669 crossref_primary_10_1016_j_cjca_2017_06_002 crossref_primary_10_1016_j_cjca_2019_06_007 crossref_primary_10_1016_j_cjca_2019_06_006 crossref_primary_10_1016_j_hrthm_2015_06_029 crossref_primary_10_1136_practneurol_2018_002089 crossref_primary_10_1160_TH16_06_0487 crossref_primary_10_1177_0394936219836652 crossref_primary_10_1161_JAHA_118_010854 crossref_primary_10_1097_WCO_0000000000000780 crossref_primary_10_1111_bcp_12911 crossref_primary_10_1160_TH15_02_0154 crossref_primary_10_4997_jrcpe_2017_105 crossref_primary_10_1160_TH15_02_0158 crossref_primary_10_1016_j_mcna_2019_05_006 crossref_primary_10_1002_joa3_12095 crossref_primary_10_1016_j_ijcard_2016_04_139 crossref_primary_10_1016_j_ahj_2021_01_012 crossref_primary_10_1016_j_ccep_2023_01_006 crossref_primary_10_1093_europace_euab280 crossref_primary_10_1371_journal_pone_0197583 crossref_primary_10_1007_s12630_021_01944_0 crossref_primary_10_1017_cem_2019_399 crossref_primary_10_1136_heartjnl_2020_317741 crossref_primary_10_1016_j_jacc_2015_08_856 crossref_primary_10_1016_j_annemergmed_2019_03_026 crossref_primary_10_1016_j_jacep_2018_06_001 crossref_primary_10_1016_j_cjca_2017_02_004 crossref_primary_10_1007_s11739_019_02169_2 crossref_primary_10_1007_s11886_015_0618_4 crossref_primary_10_1016_j_rccar_2016_10_022 crossref_primary_10_1016_j_thromres_2021_05_005 crossref_primary_10_1016_j_jtcvs_2023_03_004 crossref_primary_10_1177_2048872618799748 crossref_primary_10_1161_STROKEAHA_115_008714 crossref_primary_10_1136_heartjnl_2016_309832 crossref_primary_10_1016_j_amjcard_2018_04_048 crossref_primary_10_5937_siks1601018P crossref_primary_10_1093_ndt_gfz040 crossref_primary_10_1016_S1131_3587_16_30012_7 crossref_primary_10_1093_europace_euv235 crossref_primary_10_1016_S0140_6736_19_32994_0 crossref_primary_10_1016_j_cjca_2015_10_002 crossref_primary_10_1093_eurheartj_ehv177 crossref_primary_10_1161_JAHA_115_002322 crossref_primary_10_3389_fmed_2023_1212816 crossref_primary_10_1007_s11886_016_0747_4 crossref_primary_10_1016_j_amjcard_2016_04_014 crossref_primary_10_1016_j_annemergmed_2018_09_001 crossref_primary_10_1016_j_cjca_2016_01_014 crossref_primary_10_1007_s11897_023_00586_1 crossref_primary_10_1016_j_cjca_2016_01_016 crossref_primary_10_1016_j_cjca_2018_11_023 crossref_primary_10_1016_j_ahj_2016_02_003 crossref_primary_10_1097_CCM_0000000000002325 crossref_primary_10_1016_j_cjca_2015_08_004 crossref_primary_10_1016_j_jacc_2016_11_061 crossref_primary_10_3390_ijms22010282 crossref_primary_10_1016_j_tcm_2018_11_003 crossref_primary_10_1016_j_ahj_2017_04_008 crossref_primary_10_1016_j_cjca_2016_02_056 crossref_primary_10_1016_j_ijcard_2016_03_008 crossref_primary_10_2196_28266 crossref_primary_10_1586_14779072_2016_1164033 crossref_primary_10_1016_j_jacep_2020_04_017 crossref_primary_10_1016_j_cjca_2016_01_013 crossref_primary_10_1111_ijcp_13285 crossref_primary_10_1016_j_ahj_2016_07_015 crossref_primary_10_1160_TH15_03_0247 crossref_primary_10_1016_j_cjca_2014_09_018 crossref_primary_10_1016_j_emc_2017_03_004 crossref_primary_10_1080_03007995_2017_1409425 crossref_primary_10_1016_j_hrthm_2016_05_021 crossref_primary_10_1017_cem_2017_20 crossref_primary_10_1007_s40264_017_0539_9 crossref_primary_10_1093_europace_euy246 crossref_primary_10_1016_j_amjcard_2015_08_049 crossref_primary_10_1177_1747493017694391 crossref_primary_10_1016_j_cjca_2015_07_012 crossref_primary_10_1007_s10557_015_6632_3 crossref_primary_10_1016_j_cjca_2016_05_009 crossref_primary_10_1007_s12325_016_0458_7 crossref_primary_10_1080_00015385_2018_1494089 crossref_primary_10_1136_postgradmedj_2016_134159 crossref_primary_10_1001_jamanetworkopen_2021_21867 crossref_primary_10_1016_j_cjca_2014_10_018 crossref_primary_10_1177_1747493016669885 crossref_primary_10_1016_j_mayocp_2020_11_031 crossref_primary_10_1016_j_iccl_2021_11_006 crossref_primary_10_1038_nrcardio_2015_7 crossref_primary_10_1007_s43678_021_00103_0 crossref_primary_10_1016_j_cjca_2016_02_031 crossref_primary_10_1016_j_ahj_2018_04_008 crossref_primary_10_1161_CIRCRESAHA_116_306925 crossref_primary_10_1093_ehjcvp_pvaa120 crossref_primary_10_1016_j_cjca_2019_03_001 crossref_primary_10_1136_openhrt_2016_000441 crossref_primary_10_1161_CIRCEP_119_007437 crossref_primary_10_1177_2047487316632628 crossref_primary_10_1016_j_cjca_2016_05_016 crossref_primary_10_1586_14779072_2016_1154457 crossref_primary_10_1016_j_rce_2017_02_014 crossref_primary_10_1017_cem_2017_421 crossref_primary_10_1186_s13012_016_0523_2 crossref_primary_10_1080_14656566_2018_1515913 crossref_primary_10_1093_europace_eux177 crossref_primary_10_1097_FJC_0000000000000297 crossref_primary_10_1177_1060028017699635 crossref_primary_10_1093_europace_euaa365 crossref_primary_10_1016_j_cjca_2016_09_002 crossref_primary_10_1016_j_annemergmed_2014_12_010 crossref_primary_10_1016_j_ajem_2018_01_066 crossref_primary_10_1016_j_cjca_2017_12_012 crossref_primary_10_1016_j_hrthm_2015_07_017 crossref_primary_10_1111_acem_13303 crossref_primary_10_26442_00403660_2021_02_200611 crossref_primary_10_20996_1819_6446_2020_04_16 crossref_primary_10_1016_j_ahj_2016_01_010 crossref_primary_10_1016_j_cjca_2018_01_001 crossref_primary_10_1016_j_ahj_2016_08_008 crossref_primary_10_1016_j_cjca_2020_04_026 crossref_primary_10_1016_j_cjco_2021_04_014 crossref_primary_10_1016_S0140_6736_16_31258_2 crossref_primary_10_1016_j_clinthera_2015_09_008 crossref_primary_10_1016_j_rceng_2017_02_003 crossref_primary_10_1111_1755_5922_12310 crossref_primary_10_1093_eurheartj_ehy345 crossref_primary_10_1016_j_ccl_2021_04_005 crossref_primary_10_9778_cmajo_20180001 crossref_primary_10_1093_ehjcvp_pvw022 crossref_primary_10_1371_journal_pone_0213379 crossref_primary_10_1097_JCN_0000000000000653 crossref_primary_10_1097_MD_0000000000000849 crossref_primary_10_3389_fcvm_2022_847286 crossref_primary_10_1016_j_ijcard_2014_11_196 crossref_primary_10_1007_s10840_017_0223_0 crossref_primary_10_1111_jcpt_12846 crossref_primary_10_1159_000445329 crossref_primary_10_1161_CIRCRESAHA_116_308407 crossref_primary_10_1016_j_cjca_2015_07_008 crossref_primary_10_1016_j_jacc_2015_08_032 crossref_primary_10_1161_JAHA_117_007603 crossref_primary_10_1016_j_cjca_2019_08_040 crossref_primary_10_1016_j_ahj_2018_05_020 crossref_primary_10_1016_j_cjca_2015_03_022 crossref_primary_10_1080_07853890_2021_1893897 crossref_primary_10_3310_eme08180 crossref_primary_10_5500_wjt_v9_i6_134 crossref_primary_10_1016_j_jacc_2016_12_038 crossref_primary_10_1016_j_cjca_2020_10_001 crossref_primary_10_1007_s43678_021_00167_y crossref_primary_10_1016_j_hrthm_2017_02_019 crossref_primary_10_1007_s00059_014_4196_9 crossref_primary_10_1016_j_cjca_2015_06_005 crossref_primary_10_1161_CIRCULATIONAHA_121_057095 crossref_primary_10_1111_ijcp_14305 crossref_primary_10_1182_asheducation_2018_1_348 crossref_primary_10_1017_cem_2016_353 crossref_primary_10_1586_14779072_2015_1011128 crossref_primary_10_1053_j_ajkd_2018_02_360 crossref_primary_10_3390_ijerph18010137 crossref_primary_10_1016_j_hoc_2016_05_005 crossref_primary_10_1097_HCO_0000000000000264 crossref_primary_10_1016_j_ijcard_2016_08_091 crossref_primary_10_1055_s_0040_1714654 crossref_primary_10_1186_s13063_023_07230_2 crossref_primary_10_15420_japsc_2021_32 crossref_primary_10_1253_circj_CJ_15_0307 crossref_primary_10_1177_1747493016687579 crossref_primary_10_1016_j_cjca_2021_06_011 crossref_primary_10_1016_j_hrthm_2015_09_019 crossref_primary_10_1016_j_ijcard_2015_11_035 crossref_primary_10_1186_s13063_018_2487_9 crossref_primary_10_1371_journal_pone_0175405 crossref_primary_10_1016_j_annemergmed_2015_03_024 crossref_primary_10_1016_j_ahj_2015_10_021 crossref_primary_10_1016_j_jemermed_2022_07_016 crossref_primary_10_1016_j_ijcha_2015_02_001 crossref_primary_10_1016_j_jemermed_2022_07_014 crossref_primary_10_1097_MBC_0000000000000434 crossref_primary_10_3390_medicina57050422 crossref_primary_10_1016_j_cjca_2015_06_025 crossref_primary_10_1080_09168451_2019_1597620 crossref_primary_10_1097_MD_0000000000003992 crossref_primary_10_1371_journal_pone_0291299 crossref_primary_10_1016_j_cjca_2016_03_011 crossref_primary_10_1016_j_jacc_2014_10_045 crossref_primary_10_1097_MD_0000000000007679 crossref_primary_10_1016_j_rccl_2019_04_007 crossref_primary_10_1161_STROKEAHA_119_027123 crossref_primary_10_1186_s12882_017_0809_x crossref_primary_10_9778_cmajo_20200055 crossref_primary_10_1016_j_jfma_2016_10_005 crossref_primary_10_1016_j_hrthm_2015_08_017 crossref_primary_10_1161_STROKEAHA_115_011979 crossref_primary_10_1155_2020_7351876 crossref_primary_10_1016_j_rccl_2019_04_001 crossref_primary_10_1136_bmjebm_2018_111098 crossref_primary_10_1161_STROKEAHA_115_009095 crossref_primary_10_1093_cvr_cvaa258 crossref_primary_10_1016_j_cjca_2014_05_022 crossref_primary_10_1016_j_cjca_2016_07_591 crossref_primary_10_1161_JAHA_116_004065 crossref_primary_10_1016_j_ebiom_2016_01_017 crossref_primary_10_1177_1715163519866232 crossref_primary_10_1007_s43678_020_00054_y crossref_primary_10_1016_j_jjcc_2020_01_010 crossref_primary_10_1016_j_cjca_2020_09_001 crossref_primary_10_1016_j_ccl_2017_08_008 crossref_primary_10_1016_j_amjcard_2015_12_055 crossref_primary_10_1017_cem_2018_415 crossref_primary_10_1016_j_cjca_2015_06_011 crossref_primary_10_1177_1753944717714921 crossref_primary_10_1016_j_cjca_2014_11_022 crossref_primary_10_1016_j_cjca_2014_11_021 crossref_primary_10_1177_1474515115575645 crossref_primary_10_1016_j_cjca_2014_11_027 crossref_primary_10_1253_circj_CJ_15_0095 crossref_primary_10_1001_jamasurg_2018_0374 crossref_primary_10_1002_clc_23085 crossref_primary_10_1177_17151635211058160 crossref_primary_10_1007_s40256_016_0161_8 crossref_primary_10_1017_cem_2018_26 crossref_primary_10_1097_MNH_0000000000000098 crossref_primary_10_1136_bmjopen_2017_018180 crossref_primary_10_1253_circj_CJ_15_0653 crossref_primary_10_1016_j_annemergmed_2016_10_013 crossref_primary_10_9778_cmajo_20150096 crossref_primary_10_1016_j_ccep_2016_02_010 |
| Cites_doi | 10.1161/CIR.0000000000000040 10.1016/j.annemergmed.2004.02.016 10.1161/CIRCULATIONAHA.113.007825 10.1161/01.CIR.0000145172.55640.93 10.1161/CIRCEP.108.824789 10.2215/CJN.02400311 10.1056/NEJMoa1007432 10.1111/j.1540-8167.2011.02050.x 10.1161/CIRCULATIONAHA.112.105221 10.1016/j.cjca.2012.01.021 10.1016/j.jacc.2010.05.061 10.1001/jama.2014.467 10.1093/eurheartj/ehs348 10.1161/STROKEAHA.107.485110 10.1161/CIRCEP.109.856633 10.1016/S0196-0644(99)70300-8 10.1161/CIRCULATIONAHA.112.114389 10.1016/j.annemergmed.2010.04.006 10.1161/CIRCEP.113.000612 10.1111/j.1365-2125.2010.03753.x 10.1016/j.jacc.2011.04.010 10.1016/j.cjca.2012.08.019 10.1056/NEJMoa1113566 10.1016/S1474-4422(13)70310-7 10.1016/S0140-6736(07)61233-1 10.1111/jce.12267 10.1016/j.hrthm.2013.07.002 10.1378/chest.09-1584 10.1378/chest.11-2304 10.1056/NEJMoa1105575 10.1161/CIRCEP.109.849638 10.1378/chest.11-2298 10.1016/j.jacc.2012.11.064 10.1016/j.cjca.2010.11.001 10.1093/eurheartj/eht120 10.1253/circj.CJ-11-0763 10.1111/acem.12016 10.1345/aph.1H295 10.7326/0003-4819-146-12-200706190-00007 10.1016/S0140-6736(12)60570-4 10.1016/j.jacc.2011.08.068 10.1160/TH13-01-0054 10.1161/STROKEAHA.112.676551 10.1161/STROKEAHA.113.001927 10.1001/jamainternmed.2013.1561 10.1016/j.hrthm.2011.04.022 10.1056/NEJMoa1313600 10.1016/j.cjca.2011.03.002 10.1016/j.jacc.2012.03.019 10.1161/CIRCULATIONAHA.111.029801 10.1111/j.1553-2712.2010.00697.x 10.1093/eurheartj/eht328 10.1093/eurheartj/ehi583 10.1161/CIRCOUTCOMES.111.963108 10.1161/CIRCEP.109.923771 10.1016/S0828-282X(10)70408-6 10.1161/JAHA.112.004549 10.1016/j.cjca.2013.07.375 10.1161/CIRCEP.111.964916 10.1136/heartjnl-2011-300720 10.1161/CIRCEP.113.000768 10.1161/STROKEAHA.113.003788 10.1161/CIRCEP.113.000320 10.1056/NEJMoa1310907 10.1161/CIRCULATIONAHA.111.090464 10.1136/bmj.d124 10.1016/j.hrthm.2012.06.039 10.1017/S1481803500012227 10.1016/j.jacc.2012.09.033 10.1160/TH12-02-0093 10.1016/j.cjca.2010.11.014 10.1016/j.hrthm.2011.07.025 10.1161/CIRCULATIONAHA.109.921320 10.1161/CIRCULATIONAHA.113.002332 10.1016/j.jacc.2011.12.014 10.1056/NEJMoa1009638 10.1016/j.hrthm.2011.03.050 10.1016/j.hrthm.2013.11.009 10.1016/S0140-6736(13)62343-0 10.1056/NEJMoa1302946 10.1056/NEJMoa1107039 10.1136/heartjnl-2013-304386 10.1097/MJT.0b013e31821106c9 10.1161/CIRCULATIONAHA.108.772582 10.1016/S0140-6736(09)61343-X 10.7326/0003-4819-147-8-200710160-00018 10.1056/NEJMoa0905561 10.1161/CIRCULATIONAHA.113.003862 10.1212/WNL.0000000000000145 10.1371/journal.pone.0067602 10.1001/archinte.1997.00440320143013 10.1016/j.annemergmed.2010.08.041 10.1161/CIRCULATIONAHA.112.107128 10.1093/eurheartj/eht557 10.1001/jama.285.22.2864 10.1001/jama.2009.2029 10.1161/STROKEAHA.113.003433 10.1016/S0735-1097(02)02052-1 10.1056/NEJM199705223362107 10.1016/j.jacc.2013.11.039 10.1212/WNL.0b013e3182a2cc15 10.1016/j.jacc.2013.02.035 10.1378/chest.13-2103 10.1016/j.jacc.2013.04.089 10.1016/j.hrthm.2012.12.011 |
| ContentType | Journal Article |
| Copyright | Canadian Cardiovascular Society 2014 Canadian Cardiovascular Society Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: Canadian Cardiovascular Society – notice: 2014 Canadian Cardiovascular Society – notice: Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. |
| CorporateAuthor | CCS Atrial Fibrillation Guidelines Committee |
| CorporateAuthor_xml | – name: CCS Atrial Fibrillation Guidelines Committee |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.1016/j.cjca.2014.08.001 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1916-7075 |
| EndPage | 1130 |
| ExternalDocumentID | 10_1016_j_cjca_2014_08_001 25262857 S0828282X14012495 1_s2_0_S0828282X14012495 |
| Genre | Journal Article Practice Guideline |
| GeographicLocations | Canada |
| GeographicLocations_xml | – name: Canada |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1P~ 1~. 1~5 29B 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 8P~ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABXDB ACDAQ ACGFO ACJTP ACRLP ADBBV ADEZE ADMUD ADVLN AEBSH AEKER AENEX AEVXI AFCTW AFJKZ AFKWA AFRHN AFTJW AFXBA AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV E3Z EBS EFJIC EJD F5P FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HX~ HYE HZ~ J1W KOM M41 MO0 O-L O9- OAUVE OA~ OK1 OL0 P-8 P-9 P2P PC. Q38 ROL RPM SDF SEL SES SJN SNG SPCBC SSH SSZ T5K TR2 Z5R ~G- AAIAV ABLVK ABYKQ AISVY AJBFU EFLBG LCYCR NAHTW CGR CUY CVF ECM EIF NPM AAYXX ACRPL ADNMO CITATION 7X8 |
| ID | FETCH-LOGICAL-c477t-1596a588c8bb5a48aa2c93dc0a191c5a9a16220402173f36899027e878079edd3 |
| IEDL.DBID | AIKHN |
| ISSN | 0828-282X |
| IngestDate | Fri Oct 25 10:57:59 EDT 2024 Fri Dec 06 03:40:18 EST 2024 Sat Sep 28 07:55:46 EDT 2024 Fri Feb 23 02:30:31 EST 2024 Tue Oct 15 22:57:02 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Language | English |
| License | Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c477t-1596a588c8bb5a48aa2c93dc0a191c5a9a16220402173f36899027e878079edd3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Instructional Material/Guideline-2 ObjectType-Feature-3 content type line 23 |
| PMID | 25262857 |
| PQID | 1566408376 |
| PQPubID | 23479 |
| PageCount | 17 |
| ParticipantIDs | proquest_miscellaneous_1566408376 crossref_primary_10_1016_j_cjca_2014_08_001 pubmed_primary_25262857 elsevier_sciencedirect_doi_10_1016_j_cjca_2014_08_001 elsevier_clinicalkeyesjournals_1_s2_0_S0828282X14012495 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-10-01 |
| PublicationDateYYYYMMDD | 2014-10-01 |
| PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Canadian journal of cardiology |
| PublicationTitleAlternate | Can J Cardiol |
| PublicationYear | 2014 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Saposnik, Gladstone, Raptis, Zhou, Hart (bib9) 2013; 44 Stabile, Bertaglia, Senatore (bib96) 2006; 27 Holmes, Reddy, Turi (bib48) 2009; 374 Packer, Irwin, Champagne (bib95) 2010; 55 Stiell, Macle (bib53) 2011; 27 Majeed, Hwang, Connolly (bib22) 2013; 128 Accessed May 13, 2014. Gupta, Perera, Ganesan (bib92) 2013; 6 Siegal, Yudin, Kaatz (bib65) 2012; 126 Santangeli, Di Biase, Horton (bib104) 2012; 5 Apostolakis, Guo, Lane, Buller, Lip (bib27) 2013; 34 Xavier Scheuermeyer, Grafstein, Stenstrom (bib58) 2010; 17 Lip, Nieuwlaat, Pisters, Lane, Crijns (bib4) 2010; 137 Accessed May 13, 2014. Gage, Waterman, Shannon (bib3) 2001; 285 Rogenstein, Kelly, Mason (bib52) 2012; 19 Burton, Vinson, Drummond (bib55) 2004; 44 Mant, Hobbs, Fletcher (bib13) 2007; 370 Brambatti, Connolly, Gold (bib45) 2014; 129 Vogt, Heintze, Gutleben (bib102) 2013; 61 Gallagher, Hennessy, Edvardsson (bib56) 2002; 40 Piccini, Lopes, Kong (bib98) 2009; 2 Lakkireddy, Reddy, Di Biase (bib110) 2014; 63 Beyer-Westendorf, Gelbricht, Forster (bib68) 2014; 35 (bib12) 1997; 157 Hummel, Michaud, Hoyt (bib85) 2014; 11 Shah, Freeman, Shilane (bib90) 2012; 59 Granger, Alexander, McMurray (bib17) 2011; 365 Culebras, Messe, Chaturvedi, Kase, Gronseth (bib34) 2014; 82 Wallmann, Tuller, Wustmann (bib39) 2007; 38 Morillo, Verma, Connolly (bib75) 2014; 311 Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study). Available at You, Singer, Howard (bib8) 2012; 141 Verma, Debruyne, Nardi (bib88) 2013; 6 Wachter, Weber-Kruger, Seegers (bib38) 2013; 260 Kim, She, Jongnarangsin (bib107) 2013; 10 Reynolds, Gunnarsson, Hunter (bib113) 2012; 5 Ruff, Giugliano, Braunwald (bib19) 2014; 383 Weerasooriya, Khairy, Litalien (bib99) 2011; 57 Verma, Champagne, Sapp (bib115) 2013; 173 Hart, Pearce, Aguilar (bib7) 2007; 146 Bassiouny, Saliba, Rickard (bib108) 2013; 6 McGrath, Kapral, Fang (bib31) 2013; 81 Reddy, Doshi, Sievert (bib49) 2013; 127 Higgins, MacFarlane, Dawson (bib36) 2013; 44 Douketis, Spyropoulos, Spencer (bib61) 2012; 141 PERIOP 2-A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin. Available at Birnie, Healey, Wells (bib63) 2013; 368 Kubitza, Becka, Mueck (bib73) 2010; 70 Gaita, Leclercq, Schumacher (bib87) 2011; 22 Healey, Martin, Duncan (bib47) 2013; 29 Roldan, Marin, Manzano-Fernandez (bib26) 2013; 109 FDA Drug Safety Communication: FDA study of Medicare patients finds risks lower for stroke and death but higher for gastrointestinal bleeding with Pradaxa (dabigatran) compared to warfarin. Available at Vallakati, Chandra, Pednekar, Frankel, Shani (bib78) 2013; 20 Olesen, Lip, Hansen (bib6) 2011; 342 Kochhauser, Dechering, Dittrich (bib40) 2014; 45 Hart, Diener, Coutts (bib35) 2014; 13 Weber-Kruger, Groschel, Mende (bib41) 2013; 8 Giugliano, Ruff, Braunwald (bib18) 2013; 369 Green, Guerra, Krahn (bib93) 2011; 27 Aguilar, Hart (bib11) 2005 Tsuchiya (bib111) 2011; 75 Airaksinen, Gronberg, Nuotio (bib59) 2013; 62 Pradax product monograph. Available at Di Biase (bib105) 2013 Patatanian, Fugate (bib64) 2006; 40 Gheorghiade, Fonarow, van Veldhuisen (bib77) 2013; 34 Lakkireddy, Reddy, Di Biase (bib106) 2012; 59 Banerjee, Fauchier, Vourc'h (bib29) 2014; 145 Hoyt, Bhonsale, Chilukuri (bib89) 2011; 8 Cairns, Yusuf, Cook (bib1) 2010; 26 Gillis, Verma, Talajic, Nattel, Dorian (bib74) 2011; 27 Mantha, Ansell (bib21) 2012; 108 Chao, Tsao, Ambrose (bib25) 2012; 9 Accessed June 30, 2014. Glotzer, Daoud, Wyse (bib42) 2009; 2 Healey, Connolly, Gold (bib43) 2012; 366 Deshmukh, Patel, Pant (bib91) 2013; 128 January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation 2014 Apr 10. [Epub ahead of print] Thrombosis Canada. Peri-operative management of patients who are receiving warfarin. Available at Lip, Larsen, Skjoth, Rasmussen (bib20) 2012; 60 Kishore, Vail, Majid (bib32) 2014; 45 Sanna, Diener, Passman (bib37) 2014; 370 Cosedis Nielsen, Johannessen, Raatikainen (bib80) 2012; 367 Connolly, Ezekowitz, Yusuf (bib15) 2009; 361 Schmidt, Dorwarth, Andresen (bib83) 2014; 25 Calkins, Reynolds, Spector (bib84) 2009; 2 Connolly, Eikelboom, Joyner (bib14) 2011; 364 Wilber, Pappone, Neuzil (bib97) 2010; 303 Patel, Mahaffey, Garg (bib16) 2011; 365 Hart, Pearce, Asinger, Herzog (bib30) 2011; 6 Kearon, Hirsh (bib60) 1997; 336 Herrera Siklody, Deneke, Hocini (bib86) 2011; 58 Skanes, Healey, Cairns (bib2) 2012; 28 Gage, van Walraven, Pearce (bib44) 2004; 110 Decker, Stead (bib50) 2011; 57 Lopes, Garcia, Wojdyla (bib70) 2013; 29 Providencia, Albenque, Combes (bib109) 2014; 100 Daoud, Glotzer, Wyse (bib46) 2011; 8 Michael, Stiell, Agarwal, Mandavia (bib54) 1999; 33 Bunch, May, Bair (bib114) 2013; 10 Healey, Eikelboom, Douketis (bib69) 2012; 126 Hunter, McCready, Diab (bib112) 2012; 98 Di Biase, Burkhardt, Mohanty (bib103) 2010; 121 Hart, Pearce, Aguilar (bib10) 2007; 147 Kirchhof, Andresen, Bosch (bib79) 2012; 380 Stiell, Clement, Perry (bib57) 2010; 12 Jais, Cauchemez, Macle (bib94) 2008; 118 Seet, Friedman, Rabinstein (bib33) 2011; 124 Banerjee, Fauchier, Vourc'h (bib28) 2013; 61 Packer, Kowal, Wheelan (bib81) 2013; 61 Eliquis product monograph, l3 version 1.1. Available at Whitbeck, Charnigo, Khairy (bib76) 2013; 34 Tzou, Marchlinski, Zado (bib100) 2010; 3 Andrade, Khairy, Guerra (bib82) 2011; 8 Ganesan, Shipp, Brooks (bib101) 2013; 2 Piccini, Stevens, Chang (bib24) 2013; 127 Stiell, Birnie (bib51) 2011; 57 Can J Cardiol. 2014 Dec;30(12):1495 Can J Cardiol. 2015 Oct;31(10):1302 Stiell (10.1016/j.cjca.2014.08.001_bib53) 2011; 27 Deshmukh (10.1016/j.cjca.2014.08.001_bib91) 2013; 128 Gage (10.1016/j.cjca.2014.08.001_bib44) 2004; 110 Gheorghiade (10.1016/j.cjca.2014.08.001_bib77) 2013; 34 Healey (10.1016/j.cjca.2014.08.001_bib43) 2012; 366 10.1016/j.cjca.2014.08.001_bib71 Patel (10.1016/j.cjca.2014.08.001_bib16) 2011; 365 Patatanian (10.1016/j.cjca.2014.08.001_bib64) 2006; 40 10.1016/j.cjca.2014.08.001_bib72 Vallakati (10.1016/j.cjca.2014.08.001_bib78) 2013; 20 Olesen (10.1016/j.cjca.2014.08.001_bib6) 2011; 342 Daoud (10.1016/j.cjca.2014.08.001_bib46) 2011; 8 Majeed (10.1016/j.cjca.2014.08.001_bib22) 2013; 128 Mant (10.1016/j.cjca.2014.08.001_bib13) 2007; 370 Lakkireddy (10.1016/j.cjca.2014.08.001_bib110) 2014; 63 Skanes (10.1016/j.cjca.2014.08.001_bib2) 2012; 28 Hummel (10.1016/j.cjca.2014.08.001_bib85) 2014; 11 Connolly (10.1016/j.cjca.2014.08.001_bib15) 2009; 361 Siegal (10.1016/j.cjca.2014.08.001_bib65) 2012; 126 Higgins (10.1016/j.cjca.2014.08.001_bib36) 2013; 44 Apostolakis (10.1016/j.cjca.2014.08.001_bib27) 2013; 34 Roldan (10.1016/j.cjca.2014.08.001_bib26) 2013; 109 Green (10.1016/j.cjca.2014.08.001_bib93) 2011; 27 Weerasooriya (10.1016/j.cjca.2014.08.001_bib99) 2011; 57 Packer (10.1016/j.cjca.2014.08.001_bib81) 2013; 61 Reynolds (10.1016/j.cjca.2014.08.001_bib113) 2012; 5 Healey (10.1016/j.cjca.2014.08.001_bib69) 2012; 126 Lopes (10.1016/j.cjca.2014.08.001_bib70) 2013; 29 Airaksinen (10.1016/j.cjca.2014.08.001_bib59) 2013; 62 Mantha (10.1016/j.cjca.2014.08.001_bib21) 2012; 108 Kochhauser (10.1016/j.cjca.2014.08.001_bib40) 2014; 45 Stiell (10.1016/j.cjca.2014.08.001_bib57) 2010; 12 Ruff (10.1016/j.cjca.2014.08.001_bib19) 2014; 383 Providencia (10.1016/j.cjca.2014.08.001_bib109) 2014; 100 Healey (10.1016/j.cjca.2014.08.001_bib47) 2013; 29 Piccini (10.1016/j.cjca.2014.08.001_bib98) 2009; 2 Hoyt (10.1016/j.cjca.2014.08.001_bib89) 2011; 8 Seet (10.1016/j.cjca.2014.08.001_bib33) 2011; 124 Calkins (10.1016/j.cjca.2014.08.001_bib84) 2009; 2 Whitbeck (10.1016/j.cjca.2014.08.001_bib76) 2013; 34 Verma (10.1016/j.cjca.2014.08.001_bib115) 2013; 173 Culebras (10.1016/j.cjca.2014.08.001_bib34) 2014; 82 Shah (10.1016/j.cjca.2014.08.001_bib90) 2012; 59 Hunter (10.1016/j.cjca.2014.08.001_bib112) 2012; 98 Schmidt (10.1016/j.cjca.2014.08.001_bib83) 2014; 25 Granger (10.1016/j.cjca.2014.08.001_bib17) 2011; 365 Gupta (10.1016/j.cjca.2014.08.001_bib92) 2013; 6 Tsuchiya (10.1016/j.cjca.2014.08.001_bib111) 2011; 75 10.1016/j.cjca.2014.08.001_bib23 Hart (10.1016/j.cjca.2014.08.001_bib35) 2014; 13 Burton (10.1016/j.cjca.2014.08.001_bib55) 2004; 44 Bunch (10.1016/j.cjca.2014.08.001_bib114) 2013; 10 Tzou (10.1016/j.cjca.2014.08.001_bib100) 2010; 3 Andrade (10.1016/j.cjca.2014.08.001_bib82) 2011; 8 Cairns (10.1016/j.cjca.2014.08.001_bib1) 2010; 26 McGrath (10.1016/j.cjca.2014.08.001_bib31) 2013; 81 Cosedis Nielsen (10.1016/j.cjca.2014.08.001_bib80) 2012; 367 Lip (10.1016/j.cjca.2014.08.001_bib4) 2010; 137 Rogenstein (10.1016/j.cjca.2014.08.001_bib52) 2012; 19 Gaita (10.1016/j.cjca.2014.08.001_bib87) 2011; 22 Di Biase (10.1016/j.cjca.2014.08.001_bib105) 2013 Connolly (10.1016/j.cjca.2014.08.001_bib14) 2011; 364 Saposnik (10.1016/j.cjca.2014.08.001_bib9) 2013; 44 You (10.1016/j.cjca.2014.08.001_bib8) 2012; 141 Verma (10.1016/j.cjca.2014.08.001_bib88) 2013; 6 Brambatti (10.1016/j.cjca.2014.08.001_bib45) 2014; 129 Reddy (10.1016/j.cjca.2014.08.001_bib49) 2013; 127 Gallagher (10.1016/j.cjca.2014.08.001_bib56) 2002; 40 Packer (10.1016/j.cjca.2014.08.001_bib95) 2010; 55 Weber-Kruger (10.1016/j.cjca.2014.08.001_bib41) 2013; 8 Holmes (10.1016/j.cjca.2014.08.001_bib48) 2009; 374 Di Biase (10.1016/j.cjca.2014.08.001_bib103) 2010; 121 Hart (10.1016/j.cjca.2014.08.001_bib7) 2007; 146 Hart (10.1016/j.cjca.2014.08.001_bib30) 2011; 6 Xavier Scheuermeyer (10.1016/j.cjca.2014.08.001_bib58) 2010; 17 Chao (10.1016/j.cjca.2014.08.001_bib25) 2012; 9 Ganesan (10.1016/j.cjca.2014.08.001_bib101) 2013; 2 Herrera Siklody (10.1016/j.cjca.2014.08.001_bib86) 2011; 58 Bassiouny (10.1016/j.cjca.2014.08.001_bib108) 2013; 6 Santangeli (10.1016/j.cjca.2014.08.001_bib104) 2012; 5 Lip (10.1016/j.cjca.2014.08.001_bib20) 2012; 60 Banerjee (10.1016/j.cjca.2014.08.001_bib28) 2013; 61 Birnie (10.1016/j.cjca.2014.08.001_bib63) 2013; 368 Lakkireddy (10.1016/j.cjca.2014.08.001_bib106) 2012; 59 Gage (10.1016/j.cjca.2014.08.001_bib3) 2001; 285 Kishore (10.1016/j.cjca.2014.08.001_bib32) 2014; 45 Jais (10.1016/j.cjca.2014.08.001_bib94) 2008; 118 Aguilar (10.1016/j.cjca.2014.08.001_bib11) 2005 Wallmann (10.1016/j.cjca.2014.08.001_bib39) 2007; 38 Wilber (10.1016/j.cjca.2014.08.001_bib97) 2010; 303 Stabile (10.1016/j.cjca.2014.08.001_bib96) 2006; 27 Douketis (10.1016/j.cjca.2014.08.001_bib61) 2012; 141 Sanna (10.1016/j.cjca.2014.08.001_bib37) 2014; 370 Glotzer (10.1016/j.cjca.2014.08.001_bib42) 2009; 2 Morillo (10.1016/j.cjca.2014.08.001_bib75) 2014; 311 Kearon (10.1016/j.cjca.2014.08.001_bib60) 1997; 336 Banerjee (10.1016/j.cjca.2014.08.001_bib29) 2014; 145 10.1016/j.cjca.2014.08.001_bib67 Kubitza (10.1016/j.cjca.2014.08.001_bib73) 2010; 70 (10.1016/j.cjca.2014.08.001_bib12) 1997; 157 Piccini (10.1016/j.cjca.2014.08.001_bib24) 2013; 127 10.1016/j.cjca.2014.08.001_bib66 Beyer-Westendorf (10.1016/j.cjca.2014.08.001_bib68) 2014; 35 Kim (10.1016/j.cjca.2014.08.001_bib107) 2013; 10 10.1016/j.cjca.2014.08.001_bib5 10.1016/j.cjca.2014.08.001_bib62 Stiell (10.1016/j.cjca.2014.08.001_bib51) 2011; 57 Wachter (10.1016/j.cjca.2014.08.001_bib38) 2013; 260 Michael (10.1016/j.cjca.2014.08.001_bib54) 1999; 33 Gillis (10.1016/j.cjca.2014.08.001_bib74) 2011; 27 Vogt (10.1016/j.cjca.2014.08.001_bib102) 2013; 61 Giugliano (10.1016/j.cjca.2014.08.001_bib18) 2013; 369 Hart (10.1016/j.cjca.2014.08.001_bib10) 2007; 147 Decker (10.1016/j.cjca.2014.08.001_bib50) 2011; 57 Kirchhof (10.1016/j.cjca.2014.08.001_bib79) 2012; 380 |
| References_xml | – volume: 26 start-page: 353 year: 2010 end-page: 358 ident: bib1 article-title: Canadian network and centre for trials internationally (cannectin): A national network for canadian-led trials in cardiovascular diseases and diabetes mellitus publication-title: Can J Cardiol contributor: fullname: Cook – volume: 57 start-page: 160 year: 2011 end-page: 166 ident: bib99 article-title: Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? publication-title: J Am Coll Cardiol contributor: fullname: Litalien – volume: 38 start-page: 2292 year: 2007 end-page: 2294 ident: bib39 article-title: Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy publication-title: Stroke contributor: fullname: Wustmann – volume: 5 start-page: 302 year: 2012 end-page: 311 ident: bib104 article-title: Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis publication-title: Circ Arrhythm Electrophysiol contributor: fullname: Horton – volume: 383 start-page: 955 year: 2014 end-page: 962 ident: bib19 article-title: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials publication-title: Lancet contributor: fullname: Braunwald – volume: 2 start-page: 349 year: 2009 end-page: 361 ident: bib84 article-title: Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses publication-title: Circ Arrhythm Electrophysiol contributor: fullname: Spector – volume: 75 start-page: 2312 year: 2011 end-page: 2313 ident: bib111 article-title: Can we stop warfarin after AF ablation? publication-title: Circ J contributor: fullname: Tsuchiya – volume: 8 start-page: 1416 year: 2011 end-page: 1423 ident: bib46 article-title: Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of trends publication-title: Heart Rhythm contributor: fullname: Wyse – volume: 374 start-page: 534 year: 2009 end-page: 542 ident: bib48 article-title: Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial publication-title: Lancet contributor: fullname: Turi – volume: 34 start-page: 1489 year: 2013 end-page: 1497 ident: bib77 article-title: Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial publication-title: Eur Heart J contributor: fullname: van Veldhuisen – volume: 20 start-page: e717 year: 2013 end-page: e719 ident: bib78 article-title: Dronedarone-induced digoxin toxicity: new drug, new interactions publication-title: Am J Ther contributor: fullname: Shani – volume: 61 start-page: 1707 year: 2013 end-page: 1712 ident: bib102 article-title: Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients publication-title: J Am Coll Cardiol contributor: fullname: Gutleben – volume: 6 start-page: 1082 year: 2013 end-page: 1088 ident: bib92 article-title: Complications of catheter ablation of atrial fibrillation: a systematic review publication-title: Circ Arrhythm Electrophysiol contributor: fullname: Ganesan – volume: 260 start-page: 2042 year: 2013 end-page: 2045 ident: bib38 article-title: Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study publication-title: J Neurol contributor: fullname: Seegers – volume: 157 start-page: 1237 year: 1997 end-page: 1240 ident: bib12 article-title: The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The atrial fibrillation investigators publication-title: Arch Intern Med – volume: 126 start-page: 1630 year: 2012 end-page: 1639 ident: bib65 article-title: Periprocedural heparin bridging in patients receiving vitamin k antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates publication-title: Circulation contributor: fullname: Kaatz – volume: 98 start-page: 48 year: 2012 end-page: 53 ident: bib112 article-title: Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death publication-title: Heart contributor: fullname: Diab – volume: 19 start-page: 1255 year: 2012 end-page: 1260 ident: bib52 article-title: An international view of how recent-onset atrial fibrillation is treated in the emergency department publication-title: Acad Emerg Med contributor: fullname: Mason – volume: 370 start-page: 493 year: 2007 end-page: 503 ident: bib13 article-title: Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham atrial fibrillation treatment of the aged study, BAFTA): a randomised controlled trial publication-title: Lancet contributor: fullname: Fletcher – volume: 62 start-page: 1187 year: 2013 end-page: 1192 ident: bib59 article-title: Thromboembolic complications after cardioversion of acute atrial fibrillation: the FINCV (Finnish Cardioversion) study publication-title: J Am Coll Cardiol contributor: fullname: Nuotio – volume: 129 start-page: 2094 year: 2014 end-page: 2099 ident: bib45 article-title: Temporal relationship between subclinical atrial fibrillation and embolic events publication-title: Circulation contributor: fullname: Gold – volume: 25 start-page: 1 year: 2014 end-page: 7 ident: bib83 article-title: Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German ablation registry publication-title: J Cardiovasc Electrophysiol contributor: fullname: Andresen – volume: 61 start-page: 1713 year: 2013 end-page: 1723 ident: bib81 article-title: Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic front (STOP AF) pivotal trial publication-title: J Am Coll Cardiol contributor: fullname: Wheelan – start-page: CD001925 year: 2005 ident: bib11 article-title: Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks publication-title: Cochrane Database Syst Rev contributor: fullname: Hart – volume: 365 start-page: 883 year: 2011 end-page: 891 ident: bib16 article-title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation publication-title: N Engl J Med contributor: fullname: Garg – volume: 22 start-page: 961 year: 2011 end-page: 968 ident: bib87 article-title: Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon publication-title: J Cardiovasc Electrophysiol contributor: fullname: Schumacher – volume: 6 start-page: 2599 year: 2011 end-page: 2604 ident: bib30 article-title: Warfarin in atrial fibrillation patients with moderate chronic kidney disease publication-title: Clin J Am Soc Nephrol contributor: fullname: Herzog – volume: 126 start-page: 343 year: 2012 end-page: 348 ident: bib69 article-title: Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the randomized evaluation of long-term anticoagulation therapy (RE-LY) randomized trial publication-title: Circulation contributor: fullname: Douketis – volume: 45 start-page: 884 year: 2014 end-page: 886 ident: bib40 article-title: Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke publication-title: Stroke contributor: fullname: Dittrich – volume: 336 start-page: 1506 year: 1997 end-page: 1511 ident: bib60 article-title: Management of anticoagulation before and after elective surgery publication-title: N Engl J Med contributor: fullname: Hirsh – volume: 28 start-page: 125 year: 2012 end-page: 136 ident: bib2 article-title: Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control publication-title: Can J Cardiol contributor: fullname: Cairns – volume: 29 start-page: S232 year: 2013 end-page: S233 ident: bib70 article-title: Use of apixaban and warfarin in patients undergoing invasive procedures: insights from Aristotle publication-title: Can J Cardiol contributor: fullname: Wojdyla – volume: 70 start-page: 703 year: 2010 end-page: 712 ident: bib73 article-title: Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct factor Xa inhibitor publication-title: Br J Clin Pharmacol contributor: fullname: Mueck – volume: 34 start-page: 3572 year: 2013 end-page: 3579 ident: bib27 article-title: Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial publication-title: Eur Heart J contributor: fullname: Lip – volume: 11 start-page: 202 year: 2014 end-page: 209 ident: bib85 article-title: Phased RF ablation in persistent atrial fibrillation publication-title: Heart Rhythm contributor: fullname: Hoyt – volume: 369 start-page: 2093 year: 2013 end-page: 2104 ident: bib18 article-title: Edoxaban versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med contributor: fullname: Braunwald – volume: 128 start-page: 2325 year: 2013 end-page: 2332 ident: bib22 article-title: Management and outcomes of major bleeding during treatment with dabigatran or warfarin publication-title: Circulation contributor: fullname: Connolly – volume: 366 start-page: 120 year: 2012 end-page: 129 ident: bib43 article-title: Subclinical atrial fibrillation and the risk of stroke publication-title: N Engl J Med contributor: fullname: Gold – volume: 137 start-page: 263 year: 2010 end-page: 272 ident: bib4 article-title: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation publication-title: Chest contributor: fullname: Crijns – volume: 285 start-page: 2864 year: 2001 end-page: 2870 ident: bib3 article-title: Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation publication-title: JAMA contributor: fullname: Shannon – volume: 146 start-page: 857 year: 2007 end-page: 867 ident: bib7 article-title: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation publication-title: Ann Intern Med contributor: fullname: Aguilar – volume: 127 start-page: 224 year: 2013 end-page: 232 ident: bib24 article-title: Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts publication-title: Circulation contributor: fullname: Chang – volume: 2 start-page: 474 year: 2009 end-page: 480 ident: bib42 article-title: The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study publication-title: Circ Arrhythm Electrophysiol contributor: fullname: Wyse – volume: 173 start-page: 149 year: 2013 end-page: 156 ident: bib115 article-title: Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study publication-title: JAMA Intern Med contributor: fullname: Sapp – volume: 147 start-page: 590 year: 2007 end-page: 592 ident: bib10 article-title: Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation publication-title: Ann Int Med contributor: fullname: Aguilar – volume: 45 start-page: 520 year: 2014 end-page: 526 ident: bib32 article-title: Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis publication-title: Stroke contributor: fullname: Majid – volume: 118 start-page: 2498 year: 2008 end-page: 2505 ident: bib94 article-title: Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study publication-title: Circulation contributor: fullname: Macle – volume: 58 start-page: 681 year: 2011 end-page: 688 ident: bib86 article-title: Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation comparison of different atrial fibrillation ablation technologies in a multicenter study publication-title: J Am Coll Cardiol contributor: fullname: Hocini – volume: 33 start-page: 379 year: 1999 end-page: 387 ident: bib54 article-title: Cardioversion of paroxysmal atrial fibrillation in the emergency department publication-title: Ann Emerg Med contributor: fullname: Mandavia – volume: 81 start-page: 825 year: 2013 end-page: 832 ident: bib31 article-title: Association of atrial fibrillation with mortality and disability after ischemic stroke publication-title: Neurology contributor: fullname: Fang – volume: 110 start-page: 2287 year: 2004 end-page: 2292 ident: bib44 article-title: Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin publication-title: Circulation contributor: fullname: Pearce – volume: 364 start-page: 806 year: 2011 end-page: 817 ident: bib14 article-title: Apixaban in patients with atrial fibrillation publication-title: N Engl J Med contributor: fullname: Joyner – volume: 368 start-page: 2084 year: 2013 end-page: 2093 ident: bib63 article-title: Pacemaker or defibrillator surgery without interruption of anticoagulation publication-title: N Engl J Med contributor: fullname: Wells – volume: 128 start-page: 2104 year: 2013 end-page: 2112 ident: bib91 article-title: In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures publication-title: Circulation contributor: fullname: Pant – volume: 361 start-page: 1139 year: 2009 end-page: 1151 ident: bib15 article-title: Dabigatran versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med contributor: fullname: Yusuf – volume: 108 start-page: 476 year: 2012 end-page: 484 ident: bib21 article-title: An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation publication-title: Thromb Haemost contributor: fullname: Ansell – volume: 57 start-page: 31 year: 2011 end-page: 32 ident: bib51 article-title: Managing recent-onset atrial fibrillation in the emergency department publication-title: Ann Emerg Med contributor: fullname: Birnie – volume: 55 start-page: E3015 year: 2010 end-page: E3016 ident: bib95 article-title: Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front Stop-AF pivotal trial publication-title: J Am Coll Cardiol contributor: fullname: Champagne – volume: 5 start-page: 171 year: 2012 end-page: 181 ident: bib113 article-title: Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis publication-title: Circ Cardiovasc Qual Outcomes contributor: fullname: Hunter – volume: 27 start-page: 38 year: 2011 end-page: 46 ident: bib53 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department publication-title: Can J Cardiol contributor: fullname: Macle – volume: 10 start-page: 1272 year: 2013 end-page: 1277 ident: bib114 article-title: Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score publication-title: Heart Rhythm contributor: fullname: Bair – volume: 29 start-page: 224 year: 2013 end-page: 228 ident: bib47 article-title: Pacemaker-detected atrial fibrillation in patients with pacemakers: Prevalence, predictors, and current use of oral anticoagulation publication-title: Can J Cardiol contributor: fullname: Duncan – volume: 2 start-page: e004549 year: 2013 ident: bib101 article-title: Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis publication-title: J Am Heart Assoc contributor: fullname: Brooks – volume: 365 start-page: 981 year: 2011 end-page: 992 ident: bib17 article-title: Apixaban versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med contributor: fullname: McMurray – volume: 124 start-page: 477 year: 2011 end-page: 486 ident: bib33 article-title: Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause publication-title: Circulation contributor: fullname: Rabinstein – volume: 44 start-page: 20 year: 2004 end-page: 30 ident: bib55 article-title: Electrical cardioversion of emergency department patients with atrial fibrillation publication-title: Ann Emerg Med contributor: fullname: Drummond – volume: 13 start-page: 429 year: 2014 end-page: 438 ident: bib35 article-title: Embolic strokes of undetermined source: the case for a new clinical construct publication-title: Lancet Neurol contributor: fullname: Coutts – volume: 2 start-page: 626 year: 2009 end-page: 633 ident: bib98 article-title: Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials publication-title: Circ Arrhythm Electrophysiol contributor: fullname: Kong – volume: 141 start-page: e326S year: 2012 end-page: e350S ident: bib61 article-title: Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines publication-title: Chest contributor: fullname: Spencer – volume: 35 start-page: 1888 year: 2014 end-page: 1896 ident: bib68 article-title: Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry publication-title: Eur Heart J contributor: fullname: Forster – volume: 141 start-page: e531S year: 2012 end-page: e575S ident: bib8 article-title: Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines publication-title: Chest contributor: fullname: Howard – volume: 61 start-page: 2079 year: 2013 end-page: 2087 ident: bib28 article-title: Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project publication-title: J Am Coll Cardiol contributor: fullname: Vourc'h – volume: 40 start-page: 2205 year: 2006 end-page: 2210 ident: bib64 article-title: Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction publication-title: Ann Pharmacother contributor: fullname: Fugate – volume: 27 start-page: 216 year: 2006 end-page: 221 ident: bib96 article-title: Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (catheter ablation for the cure of atrial fibrillation study) publication-title: Eur Heart J contributor: fullname: Senatore – volume: 6 start-page: 460 year: 2013 end-page: 466 ident: bib108 article-title: Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation publication-title: Circ Arrhythm Electrophysiol contributor: fullname: Rickard – volume: 40 start-page: 926 year: 2002 end-page: 933 ident: bib56 article-title: Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion publication-title: J Am Coll Cardiol contributor: fullname: Edvardsson – volume: 44 start-page: 99 year: 2013 end-page: 104 ident: bib9 article-title: Atrial fibrillation in ischemic stroke: Predicting response to thrombolysis and clinical outcomes publication-title: Stroke contributor: fullname: Hart – volume: 60 start-page: 738 year: 2012 end-page: 746 ident: bib20 article-title: Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation publication-title: J Am Coll Cardiol contributor: fullname: Rasmussen – volume: 109 start-page: 956 year: 2013 end-page: 960 ident: bib26 article-title: Does chronic kidney disease improve the predictive value of the CHADS2 and CHA publication-title: Thromb Haemost contributor: fullname: Manzano-Fernandez – volume: 82 start-page: 716 year: 2014 end-page: 724 ident: bib34 article-title: Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the guideline development subcommittee of the American Academy of Neurology publication-title: Neurology contributor: fullname: Gronseth – volume: 100 start-page: 324 year: 2014 end-page: 335 ident: bib109 article-title: Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis publication-title: Heart contributor: fullname: Combes – volume: 27 start-page: 859 year: 2011 end-page: 861 ident: bib93 article-title: 2010 Canadian Cardiovascular Society/Canadian Heart Rhythm Society training standards and maintenance of competency in adult clinical cardiac electrophysiology publication-title: Can J Cardiol contributor: fullname: Krahn – volume: 342 start-page: d124 year: 2011 ident: bib6 article-title: Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study publication-title: BMJ contributor: fullname: Hansen – volume: 370 start-page: 2478 year: 2014 end-page: 2486 ident: bib37 article-title: Cryptogenic stroke and underlying atrial fibrillation publication-title: N Engl J Med contributor: fullname: Passman – volume: 8 start-page: 1444 year: 2011 end-page: 1451 ident: bib82 article-title: Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies publication-title: Heart Rhythm contributor: fullname: Guerra – volume: 380 start-page: 238 year: 2012 end-page: 246 ident: bib79 article-title: Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (flec-sl): a prospective, randomised, open-label, blinded end point assessment trial publication-title: Lancet contributor: fullname: Bosch – volume: 8 start-page: 1869 year: 2011 end-page: 1874 ident: bib89 article-title: Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors publication-title: Heart Rhythm contributor: fullname: Chilukuri – volume: 367 start-page: 1587 year: 2012 end-page: 1595 ident: bib80 article-title: Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation publication-title: N Engl J Med contributor: fullname: Raatikainen – volume: 27 start-page: 47 year: 2011 end-page: 59 ident: bib74 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management publication-title: Can J Cardiol contributor: fullname: Dorian – volume: 8 start-page: e67602 year: 2013 ident: bib41 article-title: Excessive supraventricular ectopic activity is indicative of paroxysmal atrial fibrillation in patients with cerebral ischemia publication-title: PLoS One contributor: fullname: Mende – volume: 17 start-page: 408 year: 2010 end-page: 415 ident: bib58 article-title: Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter publication-title: Acad Emerg Med contributor: fullname: Stenstrom – volume: 44 start-page: 2525 year: 2013 end-page: 2531 ident: bib36 article-title: Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial publication-title: Stroke contributor: fullname: Dawson – volume: 311 start-page: 692 year: 2014 end-page: 700 ident: bib75 article-title: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial publication-title: JAMA contributor: fullname: Connolly – year: 2013 ident: bib105 article-title: Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the “compare” randomized trial (abstract LB01–1). Heart Rhythm Society 2013 scientific sessions; May 09, 2013 contributor: fullname: Di Biase – volume: 127 start-page: 720 year: 2013 end-page: 729 ident: bib49 article-title: Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial publication-title: Circulation contributor: fullname: Sievert – volume: 3 start-page: 237 year: 2010 end-page: 242 ident: bib100 article-title: Long-term outcome after successful catheter ablation of atrial fibrillation publication-title: Circ Arrhythm Electrophysiol contributor: fullname: Zado – volume: 12 start-page: 181 year: 2010 end-page: 191 ident: bib57 article-title: Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter publication-title: CJEM contributor: fullname: Perry – volume: 6 start-page: 835 year: 2013 end-page: 842 ident: bib88 article-title: Evaluation and reduction of asymptomatic cerebral embolism in ablation of atrial fibrillation, but high prevalence of chronic silent infarction: results of the Evaluation of Reduction of Asymptomatic Cerebral Embolism trial publication-title: Circ Arrhythm Electrophysiol contributor: fullname: Nardi – volume: 10 start-page: 483 year: 2013 end-page: 489 ident: bib107 article-title: Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation publication-title: Heart Rhythm contributor: fullname: Jongnarangsin – volume: 34 start-page: 1481 year: 2013 end-page: 1488 ident: bib76 article-title: Increased mortality among patients taking digoxin–analysis from the affirm study publication-title: Eur Heart J contributor: fullname: Khairy – volume: 59 start-page: 1168 year: 2012 end-page: 1174 ident: bib106 article-title: Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: Results from a multicenter prospective registry publication-title: J Am Coll Cardiol contributor: fullname: Di Biase – volume: 63 start-page: 982 year: 2014 end-page: 988 ident: bib110 article-title: Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry publication-title: J Am Coll Cardiol contributor: fullname: Di Biase – volume: 145 start-page: 1370 year: 2014 end-page: 1382 ident: bib29 article-title: A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project publication-title: Chest contributor: fullname: Vourc'h – volume: 57 start-page: 32 year: 2011 end-page: 33 ident: bib50 article-title: Selecting rate control for recent-onset atrial fibrillation publication-title: Ann Emerg Med contributor: fullname: Stead – volume: 59 start-page: 143 year: 2012 end-page: 149 ident: bib90 article-title: Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation publication-title: J Am Coll Cardiol contributor: fullname: Shilane – volume: 303 start-page: 333 year: 2010 end-page: 340 ident: bib97 article-title: Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial publication-title: JAMA contributor: fullname: Neuzil – volume: 121 start-page: 2550 year: 2010 end-page: 2556 ident: bib103 article-title: Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio publication-title: Circulation contributor: fullname: Mohanty – volume: 9 start-page: 1755 year: 2012 end-page: 1760 ident: bib25 article-title: Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation–the potential role beyond the CHA publication-title: Heart Rhythm contributor: fullname: Ambrose – ident: 10.1016/j.cjca.2014.08.001_bib5 doi: 10.1161/CIR.0000000000000040 – year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib105 contributor: fullname: Di Biase – volume: 44 start-page: 20 year: 2004 ident: 10.1016/j.cjca.2014.08.001_bib55 article-title: Electrical cardioversion of emergency department patients with atrial fibrillation publication-title: Ann Emerg Med doi: 10.1016/j.annemergmed.2004.02.016 contributor: fullname: Burton – volume: 129 start-page: 2094 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib45 article-title: Temporal relationship between subclinical atrial fibrillation and embolic events publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.007825 contributor: fullname: Brambatti – volume: 110 start-page: 2287 year: 2004 ident: 10.1016/j.cjca.2014.08.001_bib44 article-title: Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin publication-title: Circulation doi: 10.1161/01.CIR.0000145172.55640.93 contributor: fullname: Gage – volume: 2 start-page: 349 year: 2009 ident: 10.1016/j.cjca.2014.08.001_bib84 article-title: Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.108.824789 contributor: fullname: Calkins – volume: 6 start-page: 2599 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib30 article-title: Warfarin in atrial fibrillation patients with moderate chronic kidney disease publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.02400311 contributor: fullname: Hart – volume: 364 start-page: 806 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib14 article-title: Apixaban in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1007432 contributor: fullname: Connolly – start-page: CD001925 year: 2005 ident: 10.1016/j.cjca.2014.08.001_bib11 article-title: Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks publication-title: Cochrane Database Syst Rev contributor: fullname: Aguilar – volume: 22 start-page: 961 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib87 article-title: Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2011.02050.x contributor: fullname: Gaita – volume: 126 start-page: 1630 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib65 article-title: Periprocedural heparin bridging in patients receiving vitamin k antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.105221 contributor: fullname: Siegal – volume: 28 start-page: 125 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib2 article-title: Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control publication-title: Can J Cardiol doi: 10.1016/j.cjca.2012.01.021 contributor: fullname: Skanes – volume: 57 start-page: 160 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib99 article-title: Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.05.061 contributor: fullname: Weerasooriya – volume: 311 start-page: 692 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib75 article-title: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial publication-title: JAMA doi: 10.1001/jama.2014.467 contributor: fullname: Morillo – volume: 34 start-page: 1481 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib76 article-title: Increased mortality among patients taking digoxin–analysis from the affirm study publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs348 contributor: fullname: Whitbeck – volume: 38 start-page: 2292 year: 2007 ident: 10.1016/j.cjca.2014.08.001_bib39 article-title: Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy publication-title: Stroke doi: 10.1161/STROKEAHA.107.485110 contributor: fullname: Wallmann – ident: 10.1016/j.cjca.2014.08.001_bib71 – volume: 2 start-page: 626 year: 2009 ident: 10.1016/j.cjca.2014.08.001_bib98 article-title: Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.109.856633 contributor: fullname: Piccini – volume: 33 start-page: 379 year: 1999 ident: 10.1016/j.cjca.2014.08.001_bib54 article-title: Cardioversion of paroxysmal atrial fibrillation in the emergency department publication-title: Ann Emerg Med doi: 10.1016/S0196-0644(99)70300-8 contributor: fullname: Michael – volume: 127 start-page: 720 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib49 article-title: Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.114389 contributor: fullname: Reddy – volume: 57 start-page: 31 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib51 article-title: Managing recent-onset atrial fibrillation in the emergency department publication-title: Ann Emerg Med doi: 10.1016/j.annemergmed.2010.04.006 contributor: fullname: Stiell – volume: 6 start-page: 835 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib88 article-title: Evaluation and reduction of asymptomatic cerebral embolism in ablation of atrial fibrillation, but high prevalence of chronic silent infarction: results of the Evaluation of Reduction of Asymptomatic Cerebral Embolism trial publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.113.000612 contributor: fullname: Verma – volume: 70 start-page: 703 year: 2010 ident: 10.1016/j.cjca.2014.08.001_bib73 article-title: Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct factor Xa inhibitor publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2010.03753.x contributor: fullname: Kubitza – volume: 58 start-page: 681 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib86 article-title: Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation comparison of different atrial fibrillation ablation technologies in a multicenter study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.04.010 contributor: fullname: Herrera Siklody – volume: 29 start-page: 224 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib47 article-title: Pacemaker-detected atrial fibrillation in patients with pacemakers: Prevalence, predictors, and current use of oral anticoagulation publication-title: Can J Cardiol doi: 10.1016/j.cjca.2012.08.019 contributor: fullname: Healey – volume: 367 start-page: 1587 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib80 article-title: Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1113566 contributor: fullname: Cosedis Nielsen – ident: 10.1016/j.cjca.2014.08.001_bib66 – volume: 13 start-page: 429 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib35 article-title: Embolic strokes of undetermined source: the case for a new clinical construct publication-title: Lancet Neurol doi: 10.1016/S1474-4422(13)70310-7 contributor: fullname: Hart – volume: 370 start-page: 493 year: 2007 ident: 10.1016/j.cjca.2014.08.001_bib13 article-title: Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham atrial fibrillation treatment of the aged study, BAFTA): a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(07)61233-1 contributor: fullname: Mant – ident: 10.1016/j.cjca.2014.08.001_bib72 – volume: 25 start-page: 1 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib83 article-title: Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German ablation registry publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.12267 contributor: fullname: Schmidt – volume: 10 start-page: 1272 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib114 article-title: Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2013.07.002 contributor: fullname: Bunch – volume: 137 start-page: 263 year: 2010 ident: 10.1016/j.cjca.2014.08.001_bib4 article-title: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation publication-title: Chest doi: 10.1378/chest.09-1584 contributor: fullname: Lip – volume: 141 start-page: e531S year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib8 article-title: Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines publication-title: Chest doi: 10.1378/chest.11-2304 contributor: fullname: You – volume: 366 start-page: 120 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib43 article-title: Subclinical atrial fibrillation and the risk of stroke publication-title: N Engl J Med doi: 10.1056/NEJMoa1105575 contributor: fullname: Healey – volume: 2 start-page: 474 year: 2009 ident: 10.1016/j.cjca.2014.08.001_bib42 article-title: The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.109.849638 contributor: fullname: Glotzer – volume: 141 start-page: e326S year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib61 article-title: Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines publication-title: Chest doi: 10.1378/chest.11-2298 contributor: fullname: Douketis – volume: 61 start-page: 1713 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib81 article-title: Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic front (STOP AF) pivotal trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.11.064 contributor: fullname: Packer – volume: 27 start-page: 47 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib74 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management publication-title: Can J Cardiol doi: 10.1016/j.cjca.2010.11.001 contributor: fullname: Gillis – volume: 34 start-page: 1489 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib77 article-title: Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial publication-title: Eur Heart J doi: 10.1093/eurheartj/eht120 contributor: fullname: Gheorghiade – volume: 75 start-page: 2312 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib111 article-title: Can we stop warfarin after AF ablation? publication-title: Circ J doi: 10.1253/circj.CJ-11-0763 contributor: fullname: Tsuchiya – volume: 19 start-page: 1255 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib52 article-title: An international view of how recent-onset atrial fibrillation is treated in the emergency department publication-title: Acad Emerg Med doi: 10.1111/acem.12016 contributor: fullname: Rogenstein – volume: 40 start-page: 2205 year: 2006 ident: 10.1016/j.cjca.2014.08.001_bib64 article-title: Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction publication-title: Ann Pharmacother doi: 10.1345/aph.1H295 contributor: fullname: Patatanian – volume: 146 start-page: 857 year: 2007 ident: 10.1016/j.cjca.2014.08.001_bib7 article-title: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation publication-title: Ann Intern Med doi: 10.7326/0003-4819-146-12-200706190-00007 contributor: fullname: Hart – volume: 380 start-page: 238 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib79 article-title: Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (flec-sl): a prospective, randomised, open-label, blinded end point assessment trial publication-title: Lancet doi: 10.1016/S0140-6736(12)60570-4 contributor: fullname: Kirchhof – volume: 59 start-page: 143 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib90 article-title: Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.08.068 contributor: fullname: Shah – volume: 109 start-page: 956 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib26 article-title: Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? publication-title: Thromb Haemost doi: 10.1160/TH13-01-0054 contributor: fullname: Roldan – volume: 44 start-page: 99 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib9 article-title: Atrial fibrillation in ischemic stroke: Predicting response to thrombolysis and clinical outcomes publication-title: Stroke doi: 10.1161/STROKEAHA.112.676551 contributor: fullname: Saposnik – volume: 44 start-page: 2525 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib36 article-title: Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial publication-title: Stroke doi: 10.1161/STROKEAHA.113.001927 contributor: fullname: Higgins – volume: 173 start-page: 149 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib115 article-title: Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2013.1561 contributor: fullname: Verma – volume: 8 start-page: 1416 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib46 article-title: Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of trends publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2011.04.022 contributor: fullname: Daoud – volume: 55 start-page: E3015 year: 2010 ident: 10.1016/j.cjca.2014.08.001_bib95 article-title: Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front Stop-AF pivotal trial publication-title: J Am Coll Cardiol contributor: fullname: Packer – volume: 370 start-page: 2478 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib37 article-title: Cryptogenic stroke and underlying atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1313600 contributor: fullname: Sanna – volume: 27 start-page: 859 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib93 article-title: 2010 Canadian Cardiovascular Society/Canadian Heart Rhythm Society training standards and maintenance of competency in adult clinical cardiac electrophysiology publication-title: Can J Cardiol doi: 10.1016/j.cjca.2011.03.002 contributor: fullname: Green – volume: 60 start-page: 738 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib20 article-title: Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.03.019 contributor: fullname: Lip – volume: 124 start-page: 477 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib33 article-title: Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.029801 contributor: fullname: Seet – volume: 260 start-page: 2042 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib38 article-title: Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study publication-title: J Neurol contributor: fullname: Wachter – volume: 17 start-page: 408 year: 2010 ident: 10.1016/j.cjca.2014.08.001_bib58 article-title: Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter publication-title: Acad Emerg Med doi: 10.1111/j.1553-2712.2010.00697.x contributor: fullname: Xavier Scheuermeyer – volume: 34 start-page: 3572 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib27 article-title: Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial publication-title: Eur Heart J doi: 10.1093/eurheartj/eht328 contributor: fullname: Apostolakis – volume: 27 start-page: 216 year: 2006 ident: 10.1016/j.cjca.2014.08.001_bib96 article-title: Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (catheter ablation for the cure of atrial fibrillation study) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehi583 contributor: fullname: Stabile – volume: 5 start-page: 171 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib113 article-title: Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.111.963108 contributor: fullname: Reynolds – volume: 3 start-page: 237 year: 2010 ident: 10.1016/j.cjca.2014.08.001_bib100 article-title: Long-term outcome after successful catheter ablation of atrial fibrillation publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.109.923771 contributor: fullname: Tzou – volume: 26 start-page: 353 year: 2010 ident: 10.1016/j.cjca.2014.08.001_bib1 article-title: Canadian network and centre for trials internationally (cannectin): A national network for canadian-led trials in cardiovascular diseases and diabetes mellitus publication-title: Can J Cardiol doi: 10.1016/S0828-282X(10)70408-6 contributor: fullname: Cairns – volume: 2 start-page: e004549 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib101 article-title: Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis publication-title: J Am Heart Assoc doi: 10.1161/JAHA.112.004549 contributor: fullname: Ganesan – volume: 29 start-page: S232 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib70 article-title: Use of apixaban and warfarin in patients undergoing invasive procedures: insights from Aristotle publication-title: Can J Cardiol doi: 10.1016/j.cjca.2013.07.375 contributor: fullname: Lopes – volume: 5 start-page: 302 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib104 article-title: Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.111.964916 contributor: fullname: Santangeli – volume: 98 start-page: 48 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib112 article-title: Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death publication-title: Heart doi: 10.1136/heartjnl-2011-300720 contributor: fullname: Hunter – volume: 6 start-page: 1082 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib92 article-title: Complications of catheter ablation of atrial fibrillation: a systematic review publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.113.000768 contributor: fullname: Gupta – volume: 45 start-page: 884 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib40 article-title: Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke publication-title: Stroke doi: 10.1161/STROKEAHA.113.003788 contributor: fullname: Kochhauser – volume: 6 start-page: 460 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib108 article-title: Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.113.000320 contributor: fullname: Bassiouny – volume: 369 start-page: 2093 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib18 article-title: Edoxaban versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1310907 contributor: fullname: Giugliano – volume: 126 start-page: 343 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib69 article-title: Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the randomized evaluation of long-term anticoagulation therapy (RE-LY) randomized trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.090464 contributor: fullname: Healey – ident: 10.1016/j.cjca.2014.08.001_bib23 – volume: 342 start-page: d124 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib6 article-title: Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study publication-title: BMJ doi: 10.1136/bmj.d124 contributor: fullname: Olesen – volume: 9 start-page: 1755 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib25 article-title: Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation–the potential role beyond the CHA2DS2-VASc score publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2012.06.039 contributor: fullname: Chao – volume: 12 start-page: 181 year: 2010 ident: 10.1016/j.cjca.2014.08.001_bib57 article-title: Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter publication-title: CJEM doi: 10.1017/S1481803500012227 contributor: fullname: Stiell – volume: 61 start-page: 1707 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib102 article-title: Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.09.033 contributor: fullname: Vogt – volume: 108 start-page: 476 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib21 article-title: An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation publication-title: Thromb Haemost doi: 10.1160/TH12-02-0093 contributor: fullname: Mantha – volume: 27 start-page: 38 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib53 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department publication-title: Can J Cardiol doi: 10.1016/j.cjca.2010.11.014 contributor: fullname: Stiell – volume: 8 start-page: 1869 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib89 article-title: Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2011.07.025 contributor: fullname: Hoyt – volume: 121 start-page: 2550 year: 2010 ident: 10.1016/j.cjca.2014.08.001_bib103 article-title: Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.921320 contributor: fullname: Di Biase – volume: 128 start-page: 2325 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib22 article-title: Management and outcomes of major bleeding during treatment with dabigatran or warfarin publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.002332 contributor: fullname: Majeed – ident: 10.1016/j.cjca.2014.08.001_bib62 – volume: 59 start-page: 1168 year: 2012 ident: 10.1016/j.cjca.2014.08.001_bib106 article-title: Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: Results from a multicenter prospective registry publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.12.014 contributor: fullname: Lakkireddy – volume: 365 start-page: 883 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib16 article-title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1009638 contributor: fullname: Patel – volume: 8 start-page: 1444 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib82 article-title: Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2011.03.050 contributor: fullname: Andrade – volume: 11 start-page: 202 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib85 article-title: Phased RF ablation in persistent atrial fibrillation publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2013.11.009 contributor: fullname: Hummel – volume: 383 start-page: 955 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib19 article-title: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(13)62343-0 contributor: fullname: Ruff – volume: 368 start-page: 2084 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib63 article-title: Pacemaker or defibrillator surgery without interruption of anticoagulation publication-title: N Engl J Med doi: 10.1056/NEJMoa1302946 contributor: fullname: Birnie – volume: 365 start-page: 981 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib17 article-title: Apixaban versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1107039 contributor: fullname: Granger – volume: 100 start-page: 324 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib109 article-title: Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis publication-title: Heart doi: 10.1136/heartjnl-2013-304386 contributor: fullname: Providencia – volume: 20 start-page: e717 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib78 article-title: Dronedarone-induced digoxin toxicity: new drug, new interactions publication-title: Am J Ther doi: 10.1097/MJT.0b013e31821106c9 contributor: fullname: Vallakati – volume: 118 start-page: 2498 year: 2008 ident: 10.1016/j.cjca.2014.08.001_bib94 article-title: Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.772582 contributor: fullname: Jais – volume: 374 start-page: 534 year: 2009 ident: 10.1016/j.cjca.2014.08.001_bib48 article-title: Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial publication-title: Lancet doi: 10.1016/S0140-6736(09)61343-X contributor: fullname: Holmes – volume: 147 start-page: 590 year: 2007 ident: 10.1016/j.cjca.2014.08.001_bib10 article-title: Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation publication-title: Ann Int Med doi: 10.7326/0003-4819-147-8-200710160-00018 contributor: fullname: Hart – volume: 361 start-page: 1139 year: 2009 ident: 10.1016/j.cjca.2014.08.001_bib15 article-title: Dabigatran versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa0905561 contributor: fullname: Connolly – volume: 128 start-page: 2104 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib91 article-title: In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.003862 contributor: fullname: Deshmukh – volume: 82 start-page: 716 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib34 article-title: Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the guideline development subcommittee of the American Academy of Neurology publication-title: Neurology doi: 10.1212/WNL.0000000000000145 contributor: fullname: Culebras – volume: 8 start-page: e67602 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib41 article-title: Excessive supraventricular ectopic activity is indicative of paroxysmal atrial fibrillation in patients with cerebral ischemia publication-title: PLoS One doi: 10.1371/journal.pone.0067602 contributor: fullname: Weber-Kruger – volume: 157 start-page: 1237 year: 1997 ident: 10.1016/j.cjca.2014.08.001_bib12 article-title: The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The atrial fibrillation investigators publication-title: Arch Intern Med doi: 10.1001/archinte.1997.00440320143013 – ident: 10.1016/j.cjca.2014.08.001_bib67 – volume: 57 start-page: 32 year: 2011 ident: 10.1016/j.cjca.2014.08.001_bib50 article-title: Selecting rate control for recent-onset atrial fibrillation publication-title: Ann Emerg Med doi: 10.1016/j.annemergmed.2010.08.041 contributor: fullname: Decker – volume: 127 start-page: 224 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib24 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.107128 contributor: fullname: Piccini – volume: 35 start-page: 1888 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib68 article-title: Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry publication-title: Eur Heart J doi: 10.1093/eurheartj/eht557 contributor: fullname: Beyer-Westendorf – volume: 285 start-page: 2864 year: 2001 ident: 10.1016/j.cjca.2014.08.001_bib3 article-title: Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation publication-title: JAMA doi: 10.1001/jama.285.22.2864 contributor: fullname: Gage – volume: 303 start-page: 333 year: 2010 ident: 10.1016/j.cjca.2014.08.001_bib97 article-title: Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.2009.2029 contributor: fullname: Wilber – volume: 45 start-page: 520 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib32 article-title: Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis publication-title: Stroke doi: 10.1161/STROKEAHA.113.003433 contributor: fullname: Kishore – volume: 40 start-page: 926 year: 2002 ident: 10.1016/j.cjca.2014.08.001_bib56 article-title: Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(02)02052-1 contributor: fullname: Gallagher – volume: 336 start-page: 1506 year: 1997 ident: 10.1016/j.cjca.2014.08.001_bib60 article-title: Management of anticoagulation before and after elective surgery publication-title: N Engl J Med doi: 10.1056/NEJM199705223362107 contributor: fullname: Kearon – volume: 63 start-page: 982 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib110 article-title: Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.11.039 contributor: fullname: Lakkireddy – volume: 81 start-page: 825 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib31 article-title: Association of atrial fibrillation with mortality and disability after ischemic stroke publication-title: Neurology doi: 10.1212/WNL.0b013e3182a2cc15 contributor: fullname: McGrath – volume: 61 start-page: 2079 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib28 article-title: Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.02.035 contributor: fullname: Banerjee – volume: 145 start-page: 1370 year: 2014 ident: 10.1016/j.cjca.2014.08.001_bib29 article-title: A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project publication-title: Chest doi: 10.1378/chest.13-2103 contributor: fullname: Banerjee – volume: 62 start-page: 1187 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib59 article-title: Thromboembolic complications after cardioversion of acute atrial fibrillation: the FINCV (Finnish Cardioversion) study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.04.089 contributor: fullname: Airaksinen – volume: 10 start-page: 483 year: 2013 ident: 10.1016/j.cjca.2014.08.001_bib107 article-title: Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2012.12.011 contributor: fullname: Kim |
| SSID | ssj0041776 |
| Score | 2.5960383 |
| Snippet | Abstract Atrial fibrillation (AF) is an extremely common clinical problem with an important population morbidity and mortality burden. The management of AF is... Atrial fibrillation (AF) is an extremely common clinical problem with an important population morbidity and mortality burden. The management of AF is complex... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1114 |
| SubjectTerms | Algorithms Anticoagulants - therapeutic use Antithrombins - administration & dosage Aspirin - administration & dosage Atrial Fibrillation - epidemiology Atrial Fibrillation - therapy Benzimidazoles - administration & dosage beta-Alanine - administration & dosage beta-Alanine - analogs & derivatives Canada Cardiovascular Comorbidity Dabigatran Electric Countershock Humans Renal Insufficiency, Chronic - epidemiology Risk Assessment Stroke - epidemiology Stroke - prevention & control Ticlopidine - administration & dosage Ticlopidine - analogs & derivatives |
| Title | 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0828282X14012495 https://dx.doi.org/10.1016/j.cjca.2014.08.001 https://www.ncbi.nlm.nih.gov/pubmed/25262857 https://search.proquest.com/docview/1566408376 |
| Volume | 30 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9tnYT2ghiDUT4qT9rbFJovx8ljVZEVWCsEVOqbZTuO1GpKKtK-8rdzlziFCdjD1Jc0iuPkbN_9Lv7dHcCV0KkqeeF7vhHWQ3usPW2jCBeeKkOtskQX9B1yvkhmy_jTiq-OYNrHwhCt0un-Tqe32tqdGTtpjrfr9fgbJV_D34pcBKqgfAwnaI5or_Zk8vHzbNEr5DgQbY05ut6jBi52pqN5mY2h9ENB3GbydLVh_mGf_oc_WzuUP4OnDkCySfeMZ3Bkq-fwZO62yM-hpl5YXpt9Ywu23JJHz-qSIdBjfSoCPPiThcocdZPd7CnpFRHhGWLZtslvegzdZNIW-WA5xQncdSy6F7DMP3yfzjxXVcEzsRA7D_FLoniamlRrruJUqdBkUWF8ha6b4SpTQRKGuLbRWYnKKEGHDF1Xm4rUF5ktiuglDKq6sq-ACV4kmgcRzwzCmASRQ6l8ynQb6TZj0hCue1nKbZc8Q_asso0kyUuSiaRCmH4wBNGLW_ZhoajIbONWVSMD2YTSl3-N_BD4oeW9ySPRLjzY42U_qhJXFW2VqMrWe-wJUW6M6FQkQ7johvvwBiEPKe5UvH5kr2_glP51jMC3MNj92Nt3iGx2egTH738GI5y_06-3X0ZuHv8C2O_2Dg |
| link.rule.ids | 314,780,784,4502,24116,27924,27925,45585,45679 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkNpeEBRKt1AwErcq3bwcJ8cVIl0ouxdYaW-W7TgSCCWr7uba396ZxFlA0B5QLlFix8n4Md_E38wAnAmdqpIXvucbYT3Ux9rTNopw4qky1CpLdEH_ISfTZDyLr-Z8vgHnvS8M0Srd2t-t6e1q7a4MnTSHi7u74Q0FX8NjTiYCZVB-B1sxR_SLg_rHnzXPIw5Em2GOSntU3HnOdCQvc28o-FAQt3E8XWaYV7TTv9Bnq4XyHdh28JGNujfchQ1bfYL3E7dBvgc1tcLy2jRLW7DZgux5VpcMYR7rAxHgyVMOKnPETfazoZBXRINniGTbKo_kGHrIqE3xwXLyEnjoOHT7MMsvbs_Hnsup4JlYiJWH6CVRPE1NqjVXcapUaLKoML5Cw81wlakgCUOc2WiqRGWUoDmGhqtNReqLzBZF9Bk2q7qyX4AJXiSaBxHPDIKYBHFDqXyKcxvpNl7SAL73spSLLnSG7Dll95IkL0kmktJg-sEARC9u2TuF4jJml25OLWUgl6H05Yt-HwBf13w2dCRqhf-2eNr3qsQ5RRslqrJ1gy0hxo0Rm4pkAAddd6-_IOQheZ2Kr29s9QQ-jG8n1_L6cvrrED7SnY4beASbq9-N_YYYZ6WP2zH8F2DZ9VI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2014+focused+update+of+the+Canadian+Cardiovascular+Society+Guidelines+for+the+management+of+atrial+fibrillation&rft.jtitle=Canadian+journal+of+cardiology&rft.au=Verma%2C+Atul&rft.au=Cairns%2C+John+A&rft.au=Mitchell%2C+L+Brent&rft.au=Macle%2C+Laurent&rft.date=2014-10-01&rft.eissn=1916-7075&rft.volume=30&rft.issue=10&rft.spage=1114&rft_id=info:doi/10.1016%2Fj.cjca.2014.08.001&rft_id=info%3Apmid%2F25262857&rft.externalDocID=25262857 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0828282X%2FS0828282X13X00133%2Fcov150h.gif |